⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iva primary peritoneal cancer ajcc v8

Every month we try and update this database with for stage iva primary peritoneal cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal CancerNCT05415709
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Endomet...
Ovarian Mucinou...
Ovarian Serous ...
Primary Periton...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Carboplatin
Cisplatin
Cytoreductive S...
Hyperthermic In...
Paclitaxel
Quality-of-Life...
Questionnaire A...
18 Years - Ohio State University Comprehensive Cancer Center
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryNCT03943173
BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxNCT05092373
Advanced Breast...
Advanced Endome...
Advanced Fallop...
Advanced Hepato...
Advanced Malign...
Advanced Malign...
Advanced Malign...
Advanced Ovaria...
Advanced Primar...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Malignant Abdom...
Malignant Solid...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic Hepa...
Metastatic Mali...
Metastatic Mali...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Metastatic Rena...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Fallo...
Stage III Hepat...
Stage III Ovari...
Stage III Prima...
Stage III Renal...
Stage III Uteri...
Stage IIIA Fall...
Stage IIIA Hepa...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA Uter...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Hepa...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIB Uter...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Fallop...
Stage IV Hepato...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Hepat...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Hepat...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Atezolizumab
Cabozantinib S-...
Nab-paclitaxel
Tumor Treating ...
18 Years - M.D. Anderson Cancer Center
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT03735589
Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersNCT03968406
Malignant Femal...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Recurrent Vagin...
Stage IV Cervic...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IV Vagina...
Stage IVA Cervi...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVA Vagin...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Stage IVB Vagin...
Quality-of-Life...
Radiation Thera...
Talazoparib
18 Years - M.D. Anderson Cancer Center
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisNCT03508570
Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerNCT03907527
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Fall...
Refractory Ovar...
Refractory Prim...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
PRGN-3005 Ultra...
PRGN-3005 Ultra...
18 Years - Precigen, Inc
Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisNCT03508570
Malignant Perit...
Malignant Retro...
Metastatic Cerv...
Metastatic Endo...
Metastatic Fall...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Peritoneal Carc...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Refrac...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Platinum-Resist...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Malig...
Recurrent Ovari...
Recurrent Prima...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Cervi...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Ipilimumab
Laboratory Biom...
Nivolumab
Pharmacokinetic...
18 Years - M.D. Anderson Cancer Center
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialNCT04575935
Advanced Ovaria...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Fallopian Tube ...
Ovarian Clear C...
Ovarian Endomet...
Ovarian Serous ...
Ovarian Transit...
Primary Periton...
Primary Periton...
Primary Periton...
Primary Periton...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Laparotomy
Minimally Invas...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerNCT03735589
Stage II Fallop...
Stage II Ovaria...
Stage II Primar...
Stage IIA Fallo...
Stage IIA Ovari...
Stage IIA Prima...
Stage IIB Fallo...
Stage IIB Ovari...
Stage IIB Prima...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Alpha-type-1 Po...
Autologous Natu...
18 Years - Roswell Park Cancer Institute
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerNCT04498520
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before SurgeryNCT03943173
BRCA-Mutated Ov...
BRCA1 Gene Muta...
BRCA2 Gene Muta...
High Grade Fall...
High Grade Ovar...
Primary Periton...
Stage III Fallo...
Stage III Ovari...
Stage III Prima...
Stage IIIA Fall...
Stage IIIA Ovar...
Stage IIIA Prim...
Stage IIIA1 Fal...
Stage IIIA1 Ova...
Stage IIIA2 Fal...
Stage IIIA2 Ova...
Stage IIIB Fall...
Stage IIIB Ovar...
Stage IIIB Prim...
Stage IIIC Fall...
Stage IIIC Ovar...
Stage IIIC Prim...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Chemotherapy
Olaparib
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerNCT04498520
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Hormone Recepto...
Locally Advance...
Metastatic Brea...
Metastatic Endo...
Metastatic Fall...
Metastatic HER2...
Metastatic Mali...
Metastatic Ovar...
Metastatic Prim...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Prima...
Refractory Brea...
Stage IV Fallop...
Stage IV Ovaria...
Stage IV Primar...
Stage IV Uterin...
Stage IVA Fallo...
Stage IVA Ovari...
Stage IVA Prima...
Stage IVA Uteri...
Stage IVB Fallo...
Stage IVB Ovari...
Stage IVB Prima...
Stage IVB Uteri...
Abexinostat Tos...
Fulvestrant
Palbociclib
18 Years - University of California, San Francisco
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: